Abbott Laboratories shares surged 12% after the healthcare company reported strong second-quarter sales, raised its full-year earnings outlook and reaffirmed revenue growth guidance. Progress across its medical devices and diagnostics pipeline further boosted investor confidence in future growth.
Abbott Laboratories shares surged 12% after the healthcare company reported strong second-quarter sales, raised its full-year earnings outlook and reaffirmed revenue growth guidance. Progress across its medical devices and diagnostics pipeline further boosted investor confidence in future growth.
<iframe src="https://hindustansphere.com/embed/cluster/decb2750f4db4767f7a52a5e93f1534134a5ee62" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Abbott Labs shares jump 12% as Q2 sales rise, profit outlook raised"></iframe>
US listed Abbott Laboratories shares jumped 12% after the healthcare company reported stronger second-quarter sales and raised its full-year earnings outlook. The company said second-quarter sales rose 13% on a reported basis and 4.8% on a comparable basis.Abbott reported GAAP diluted earnings per share of $0.53, while adjusted diluted earnings per share came in at $1.31, excluding specified items. The company also raised its full-year 2026 adjusted diluted EPS guidance to a range of $5.45 to $…
